Cytoplasmic Transport and Nuclear Import of Plasmid DNA

Purpose: Productive gene transfer requires plasmid DNA to not only enter cells but also traffic through the cytoplasm and cross the nuclear envelope. Most transfection strategies focus on membrane entry and promoter choice, but cytoplasmic trafficking and nuclear import are critical, rate-limiting barriers—especially because cytoplasmic nucleases degrade DNA and the nuclear envelope restricts entry in non-dividing cells. ---

Hypothesis: The review’s central thesis is: if plasmid DNA is released into the cytoplasm, it rapidly associates with host proteins to form dynamic protein–DNA complexes that mediate microtubule-based trafficking toward the nucleus and sequence-specific nuclear import. DNA nuclear targeting sequences (DTSs) and specific transcription factors/importins govern nuclear entry, particularly in non-dividing cells. ---

Aims: - Review current understanding of how naked plasmid DNA traffics through the cytoplasm after transfection. - Describe the formation and composition of host protein–DNA complexes. - Explain microtubule- and actin-based cytoplasmic movement of plasmids. - Discuss nuclear envelope barriers and mechanisms of nuclear import in mitotic vs. non-dividing cells. - Review DTS elements, cell-specific and regulated nuclear entry, and cofactors involved in DNA nuclear transport. - Highlight implications for improving non-viral gene delivery. ---

Delivery system: Payload: Plasmid DNA (naked DNA or DNA released from carrier complexes). Delivery contexts reviewed: - Physical delivery: microinjection, electroporation. - Carrier-mediated delivery: liposomes/lipoplexes, polyethyleneimine, nanoparticles, cationic lipid–DNA complexes. - Viral context: SV40 enhancer-derived sequences. Engineered/functional elements: - DNA nuclear targeting sequences (DTSs): SV40 enhancer, NF-κB binding sites, glucocorticoid receptor binding sites, hypoxia-responsive element (HRE), smooth muscle γ-actin (SMGA) promoter, Flk-1, hcoA1, surfactant protein C (SPC), Sox2 regulatory region 2, T1α promoter. - Nuclear localization signal (NLS) peptides/proteins, importin β1, importin 7, importin 4, transportin, Ran, exportin/Crm1. - Cytoskeletal machinery: microtubules, dynein, kinesin, actin, myosin motors. - Modulators: HDAC6 inhibition, tubulin hyperacetylation, cyclic stretch, leptomycin B, TCHD. ---

Approach: Narrative review of published literature. Model systems discussed include: - In vitro cell lines: HeLa, COS, TC7, A549, smooth muscle cells, primary myotubes, and other cultured cells. - In vivo models: rat mesenteric vessels, mouse lung, mouse skeletal muscle, carotid angioplasty model. - Techniques/model systems: microinjection into cytoplasm or nucleus, electroporation, digitonin-permeabilized cells, Xenopus egg extract nuclear reconstitution, in situ hybridization, particle tracking, proteomics. - Disease context: gene therapy, non-viral gene delivery, transfection efficiency, tissue-specific gene expression. ---

Key methods: Techniques highlighted across cited studies: - Microinjection of plasmids into cytoplasm vs. nucleus. - Electroporation-mediated plasmid delivery. - Particle tracking of fluorescently labeled plasmids. - Peptide nucleic acid (PNA) labeling and in situ hybridization for nuclear localization. - Proteomics/mass spectrometry for protein–DNA complex composition. - In vitro microtubule-binding assays. - siRNA knockdown of candidate proteins (e.g., importin β1, importin 7, CREB, HDAC6). - Digitonin-permeabilized cell nuclear import reconstitution. - Western blotting and qPCR for plasmid nuclear content. - In vivo electroporation and gene expression assays. ---

Key results: - Cytoplasmic degradation: Plasmid DNA is degraded in HeLa and COS cell cytoplasm with a half-life of 50–90 min. - Protein–DNA complex: Over 600 proteins associate with the pEGFPN1 plasmid in transfected cells; complexes are dynamic, with some proteins binding for at least 4 h and others associating/disassociating over time. - Diffusion limit: DNA larger than 2000 bp is effectively unable to diffuse through cytoplasm in a physiological time frame due to cytoskeletal networks. - Directed movement: Plasmids containing CREB-binding sites (e.g., in the CMV promoter) move with initial velocities of 150 nm/s and up to 380 nm/s; plasmids lacking CREB sites move at <50 nm/s, consistent with diffusion. - Nuclear import efficiency: Lipofection delivers ~2,000–10,000 plasmids per cell, but only 20–1,000 are detected in the nucleus by 24–36 h. Cytoplasmic microinjection requires 30–100 times more plasmid than nuclear injection for equivalent expression. - DTS activity: The SV40 DTS increased gene expression 40- to 200-fold after electroporation into rat mesenteric vessels. - Cell-specific DTS: The SMGA DTS mediated nuclear import and expression specifically in smooth muscle cells, not endothelial cells, fibroblasts, or epithelial cells. - Mitosis: Dividing cells are about 10 times more likely to express transferred gene product than non-divided cells; DTS benefit is largely absent during mitosis. - Importin dependence: Importin β1 depletion abolished directed plasmid movement and nuclear import; importin 7 depletion had no effect in smooth muscle cells or A549 cells in some studies, though other studies reported importin 7 involvement. - HDAC6/tubulin acetylation: Inhibition or knockdown of HDAC6 increased microtubule acetylation, plasmid binding to microtubules, processivity of transport, and transfection efficiency in cells and in mouse lungs. ---

Interpretation: The authors conclude that understanding cytoplasmic trafficking and nuclear import of plasmids is vital for improving non-viral gene delivery. Plasmids exploit host protein machinery—transcription factors, importins, motor proteins, and cytoskeletal networks—to move toward and enter the nucleus. DTS elements can enhance nuclear import in a general or cell-specific manner, but their benefit is context-dependent. Overcoming the nuclear envelope barrier remains central to increasing transfection efficiency and advancing gene therapy. ---

Limitations: - Mechanisms of cytoplasmic trafficking and nuclear import remain incompletely understood. - Nuclear envelope is a major barrier in non-dividing cells; DTS elements work mainly in non-dividing cells and are less relevant during mitosis. - Some studies report limited or no benefit of DTS on gene expression, especially with strong promoters (e.g., CMV) where post-transcriptional/translational steps may dominate. - Discrepancies exist regarding the role of importin 7 in plasmid nuclear import. - Labeling methods (e.g., YOYO-1, covalent dyes) can alter plasmid nuclear import and transcriptional activity. - Mass action can drive nuclear entry in tissues (e.g., skeletal muscle) when high plasmid doses are used, independent of DTS. - In vivo validation is limited; many mechanistic findings come from cultured cells or microinjection models. - As a review, the article does not provide primary data or systematic meta-analysis.